News

Filter

Current filters:

Sweden

1 to 9 of 27 results

Pharma violates own marketing regulations, Swedish study alleges

Pharma violates own marketing regulations, Swedish study alleges

19-02-2015

A new report from Lund University in Sweden claims to show how the pharmaceutical industry, time and…

Markets & MarketingPharmaceuticalRegulationSwedenUK

Zubsolv market share boosts Orexo valuation, according to Edison research

Zubsolv market share boosts Orexo valuation, according to Edison research

10-02-2015

Swedish drug developer Orexo has laid the foundations to accelerate growth of its Zubsolv (buprenorphine…

FinancialMarkets & MarketingNeurologicalOrexoPharmaceuticalSwedenUSAZubsolv

Novo Nordisk and Karolinska Institutet collaborate on diabetes postdoctoral research program

Novo Nordisk and Karolinska Institutet collaborate on diabetes postdoctoral research program

10-02-2015

Danish insulin giant Novo Nordisk is to join forces with Swedish researchers Karolinska Institutet for…

DenmarkDiabetesNovo NordiskPharmaceuticalResearchSweden

Twin Swedish and Welsh life sciences hubs plan to share knowledge

Twin Swedish and Welsh life sciences hubs plan to share knowledge

12-12-2014

A Swedish cluster for life sciences, Medicon Village, visited the new Life Sciences Hub Wales center…

Medicon VillagePharmaceuticalResearchSwedenUK

Sobi pays $10 million to exercise opt-in right for Elocta

Sobi pays $10 million to exercise opt-in right for Elocta

21-11-2014

Nordic biotech firm Swedish Orphan Biovitrum will exercise its opt-in right to take over final development…

Biogen IdecElocateEloctaFinancialHematologyPharmaceuticalSobiSweden

Orexo captures 4% opioid dependence market share within year of Zubsolv launch

Orexo captures 4% opioid dependence market share within year of Zubsolv launch

05-11-2014

Emerging Swedish addiction specialist company Orexo has achieved success by capturing a 4% share by volume…

FinancialNeurologicalOrexo ABPharmaceuticalSwedenZubsolv

Medivir concludes Swedish agreement on Olysio-based treatment for hepatitis C

Medivir concludes Swedish agreement on Olysio-based treatment for hepatitis C

31-10-2014

Swedish drugmaker Medivir says it has entered into an agreement with Swedish county councils regarding…

Anti-viralsJanssenJohnson & JohnsonMedivirOlysioPharmaceuticalPricingRegulationSweden

SOBI increases revenues by 25%, boosted by a doubling of Orfadin sales

SOBI increases revenues by 25%, boosted by a doubling of Orfadin sales

30-10-2014

Biotech firm Swedish Orphan Biovitrum has announced total revenues of 665.9 million Swedish kronor ($99.8…

BiotechnologyBusiness FinanceOrfadinSobiSweden

1 to 9 of 27 results

COMPANY SPOTLIGHT

Menarini

Back to top